Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
The Oncologist
|
June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma
James J Harding, Robin K Kelley, Benjamin Tan, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Journal of Clinical Medicine
|
May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery
Edward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
Cancer
|
August 19, 2020
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
JCO Precision Oncology
|
September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma
Darren Cowzer, Jessica B White, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer
Darren Cowzer, Henry Walch, Pranita Atri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
JCO Precision Oncology
|
September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
Darren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
The Oncologist
|
June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma
James J Harding, Robin K Kelley, Benjamin Tan, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Journal of Clinical Medicine
|
May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery
Edward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
Cancer
|
August 19, 2020
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
JCO Precision Oncology
|
September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma
Darren Cowzer, Jessica B White, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer
Darren Cowzer, Henry Walch, Pranita Atri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
JCO Precision Oncology
|
September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
Darren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Page
of 4